Drug Search Results
More Filters [+]

ASC-47

Alternative Names: ASC-47, ASC 47, ASC47
Latest Update: 2024-08-07
Latest Update Note: News Article

Product Description

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: N/A

Route of Administration: Subcutaneous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Ascletis
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for ASC-47

Countries in Clinic:

Active Clinical Trial Count: 1

Highest Development Phases

Phase 1: Non-alcoholic Steatohepatitis

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

ASC47-101

P1

Not yet recruiting

Non-alcoholic Steatohepatitis

2024-12-01

28%

Recent News Events

Date

Type

Title

08/07/2024

News Article

Light & Wonder, Inc. Reports Second Quarter 2024 Results